The startup utilises a supramolecular technology platform to design anti-cancer drugs that home into the tumor and modulate the tumor immun...

Scientists of distinction are setting up companies but with a difference — to help solve difficult problems of business and society.

India is not known for developing drugs, let along cancer drugs, but a few small and niche firms are trying exactly that, reports ET.

RA Sengupta and Shiladitya Mashelkar have set up a Delhi-based co, Invictus Oncology, to take a modified Cisplatin to the market.